tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rapport Therapeutics sees cash runway through end of 2026
PremiumThe FlyRapport Therapeutics sees cash runway through end of 2026
1M ago
Premium
Ratings
Buy Rating for Rapport Therapeutics, Inc. Driven by Promising Phase IIa Trial and RAP Technology Potential
1M ago
Premium
Ratings
Buy Rating for Rapport Therapeutics: RAP-219’s Promising Potential in Epilepsy Treatment
1M ago
PremiumCompany AnnouncementsRapport Therapeutics Elects New Directors at Annual Meeting
3M ago
Rapport Therapeutics management to meet with Citizens JMP
Premium
The Fly
Rapport Therapeutics management to meet with Citizens JMP
3M ago
Premium
Company Announcements
Rapport Therapeutics Completes Enrollment for Phase 2a Trial
3M ago
Rapport Therapeutics sees cash runway through end of 2026
PremiumThe FlyRapport Therapeutics sees cash runway through end of 2026
4M ago
Premium
Ratings
Buy Rating for Rapport Therapeutics: Promising Precision Therapeutics for CNS Disorders
5M ago
Rapport Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Rapport Therapeutics initiated with an Outperform at Citizens JMP
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100